CUSIP 221015100COMCRVSQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
123 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Orbimed Advisors LLC | 7.17M | $55.17M | 0 | Held |
| 2 | Blackrock, Inc. | 5.06M | $38.93M | +345.9K | Added |
| 3 | Vanguard Group Inc | 3.87M | $29.83M | +401.6K | Added |
| 4 | Morgan Stanley | 3.57M | $27.47M |
| Added |
| 5 | Adams Street Partners LLC | 3.28M | $25.22M | 0 | Held |
| 6 | Point72 Asset Management, L.P. | 2.88M | $22.14M | −3.58M | Reduced |
| 7 | State Street Corp | 2.79M | $21.47M | +1.78M | Added |
| 8 | Mpm Bioimpact LLC | 2.74M | $21.13M | +2.74M | New |
| 9 | Vivo Capital, LLC | 2.23M | $17.21M | 0 | Held |
| 10 | Geode Capital Management, LLC | 1.47M | $11.35M | +16.5K | Added |
See every fund holding Corvus Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders